A Study of LY2605541 Versus Insulin Glargine on Blood Sugar

Clinical trial NCT01654380 · COMPLETED

Trial details

NCT number: NCT01654380
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Diabetes Mellitus, Type 1

Start date: 2012-07-01
Primary completion: 2013-10-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.